We then asked whether overexpressing Acsl4 affected the progression of cardiac hypertrophy and altered cardiac function after pressure overload (i.e., TAC) by examining control and Acsl4 TG mice 3 weeks after sham or TAC surgery. This evidence concerns the gene ACSL4 and cardiac hypertrophy.